« Previous
Next »
The Spine Journal
Volume 9, Issue 12
, Pages 1046-1051
, December 2009
An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery
References
- Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine; 2001;
- . Does evidence-based medicine help the development of clinical practice guidelines?. Chest. 1988;113(3 Suppl):172S–178S
- Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2:31–88
- . Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations. Eur Arch Psychiatry Neurol Sci. 1984;234:157–161
- . Incidence of postoperative deep vein thrombosis in neurosurgical patients. J Neurosurg. 1975;42:201–203
- Deep vein thrombosis after major spinal surgery: incidence in an East Asian population. Spine. 2000;25:1827–1830
- Deep venous thrombosis after posterior spinal surgery. Spine. 2000;25:2962–2967
- . Thromboembolic complications following scoliosis surgery in Scandinavia. Acta Orthop Scand. 1979;50:175–178
- . Deep vein thrombosis after major reconstructive spinal surgery. Spine. 1996;21:853–858discussion 859
- . Prevention of deep-vein thrombosis after major spinal surgery: a comparison study of external devices. J Spinal Disord. 1997;10:209–214
- . Deep vein thrombosis in lumbar spinal fusion: a prospective study of antiembolic and pneumatic compression stockings. J South Orthop Assoc. 1996;5:181–184
- . Prophylaxis of thromboembolism in spinal injuries—results of enoxaparin used in 276 patients. Spinal Cord. 2001;39:88–91
- Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J. 2004;13:9–13
- Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg Rev. 1992;15:289–294
This review article summarizes a published evidence-based guideline. It is a product of the NASS Evidence-based Guideline Development Committee, approved by the NASS Board of Directors and accepted for publication outside The Spine Journal's peer review process.
FDA device/drug status: not applicable.
Author disclosures: CMB (royalties, Life Spine; consulting, DePuy Spine, Medtronic Sofamor Danek; speaking/teaching arrangements, DePuy Spine, Stryker Spine; board of directors, North American Spine Society; other office, Applied Spine; staff/materials, Archus Orthopedics, Synthes Spine; grants, Stryker Spine; fellowship support, DePuy Spine); WCW (consulting, Stryker; scientific advisory board, Intrinsic Therapeutics; other, Blaskstone Medical, Inc.); MHH (royalties, stock ownership, consulting, scientific advisory board, Relievant Medsystems; investigator salary, Department of Defense); DKR (consultant [NASS Spring Break], Medtronic); WOS (consulting, royalties [Upcoming Committee Meeting], DePuy Spine; trips/travel, BrainLab); PGM (stock ownership, Alkermes Corporation, Schering Plough; consulting, Synthes; speaking/teaching arrangements, AO/ASIF; grants, Medtronic).
PII: S1529-9430(09)00960-7
doi: 10.1016/j.spinee.2009.09.005
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The Spine Journal
Volume 9, Issue 12
, Pages 1046-1051
, December 2009
